Anti Cardiolipin IgG - India CDSCO Medical Device Registration
Anti Cardiolipin IgG is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000352_4e8ecaf0f5e20f8dc11e743e3006faec_dd45a3810b1296a3587f4aebaa91f5ec. The license holder is Amindo Biologics Pvt. Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
License Holder
Amindo Biologics Pvt. LtdDevice Class
Approving Authority
CDSCO
Product Information
Anti Cardiolipin IgG kit is an indirect solid phase immunoassay kit for the quantitative measurement of IgG class auto-antibodies directed against Cardiolipina-ฮฒ2- glycoprotein complex in human serum or plasma. The assay is intended for in vitro diagnostic use only as an aid in the diagnosis of increased risk of thrombosis in patients with Systemic Lupus Eritematosus ##PLACEHOLDER_0## or similar disorders. Anti Cardiolipin IgG kit is intended for laboratory use only
Anti Tissue Transglutaminase IgA
URINARY CORTISOL ELISA
Anti Deamidated Gliadin Peptide IgG
Brand: c-ANCA
Anti Deamidated Gliadin Peptide IgA
Brand: c-ANCA
ALDOSTERONE ELISA
Anti MPO
Brand: c-ANCA
FREE ESTRIOL ELISA
Anti Cardiolipin IgM
Anti beta 2 Glycoprotein 1 Screen-"Anti beta 2 Glycoprotein 1 Screen is an indirect enzymelinked immunosorbent assay kit designed for the quantitative measurement of IgG or IgM class antibodies directed against the ฮฒ2
Brand: c-ANCA